The Compound Report is an educational resource. Nothing on this site constitutes medical advice or encourages personal use of any compound. Always consult a qualified healthcare provider.
Ozempic · Wegovy
Once-weekly GLP-1 receptor agonist for diabetes and obesity. Established efficacy, well-characterized safety.